Saikosaponin‑d affects the differentiation, maturation and function of monocyte‑derived dendritic cells

Ying,Zuo‑Lin; Li,Xiao‑Jie; Dang,Hong; Wang,Feng; Xu,Xiao‑Yan

doi:10.3892/etm.2014.1568

Saikosaponin‑d affects the differentiation, maturation and function of monocyte‑derived dendritic cells

Authors:
- Zuo‑Lin Ying
- Xiao‑Jie Li
- Hong Dang
- Feng Wang
- Xiao‑Yan Xu
View Affiliations

Affiliations: Department of Dermatology, Shanghai First People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200080, P.R. China, Experimental Research Center, Shanghai First People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200080, P.R. China
Published online on: February 20, 2014 https://doi.org/10.3892/etm.2014.1568
Pages: 1354-1358

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Saikosaponin‑d (Ssd) is a triterpenoid saponin derived from Bupleurum falcatum L., which has been shown to exhibit a variety of pharmacological properties, including anti‑inflammatory, antibacterial and antiviral properties. The aim of the present study was to investigate the effect of Ssd on the differentiation, maturation and function of human monocyte‑derived dendritic cells (DCs) isolated from condylomata acuminata patients. The results of the present study demonstrated that Ssd reduced the differentiation of DCs, as evidenced by decreased expression levels of cluster of differentiation (CD)1a, CD80 and CD86 molecules and increased CD14 expression. Expression levels of the mannose receptor and CD32 were also significantly elevated, which was associated with enhanced fluorescein isothiocyanate‑dextran endocytic activity. Furthermore, Ssd treatment promoted DC maturation by increasing the expression levels of CD40, CD83, CD80 and CD86. In addition, the function of mature DCs, including the secretion of IL‑12 and the stimulation of lymphocyte proliferation, was significantly increased following Ssd administration. In conclusion, the present study indicated that Ssd exhibited immunomodulatory effects and may be a novel potent chemopreventive drug candidate for the treatment of condylomata acuminata.

View Figures

View References

1	FUTURE I/II Study Group. Dillner J, Kjaer SK, Wheeler CM, et al: Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ. 341:c34932010.
2	Viera MH, Amini S, Huo R, Konda S, Block S and Berman B: Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options. Int J Dermatol. 49:733–749. 2010.
3	Le Poole C, Denman CJ and Arbiser JL: Immunosuppression may be present within condyloma acuminata. J Am Acad Dermatol. 59:967–974. 2008.PubMed/NCBI
4	Lu CN, Yuan ZG, Zhang XL, et al: Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-κB signaling pathway. Int Immunopharmacol. 14:121–126. 2012.PubMed/NCBI
5	Wong VK, Zhang MM, Zhou H, et al: Saikosaponin-d enhances the anticancer potency of TNF-α via overcoming its undesirable response of activating NF-Kappa B signalling in cancer cells. Evid Based Complement Alternat Med. 2013:7452952013.PubMed/NCBI
6	Lu XL, He SX, Ren MD, Wang YL, Zhang YX and Liu EQ: Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: involvement of CCAAT/enhancer binding protein β and cyclooxygenase-2. Mol Med Rep. 5:637–644. 2012.PubMed/NCBI
7	Zhu J, Luo C, Wang P, He Q, Zhou J and Peng H: Saikosaponin A mediates the inflammatory response by inhibiting the MAPK and NF-κB pathways in LPS-stimulated RAW 264.7 cells. Exp Ther Med. 5:1345–1350. 2013.PubMed/NCBI
8	Li DY, Gu C, Min J, Chu ZH and Ou QJ: Maturation induction of human peripheral blood mononuclear cell-derived dendritic cells. Exp Ther Med. 4:131–134. 2012.PubMed/NCBI
9	Ghannam S, Pène J, Torcy-Moquet G, Jorgensen C and Yssel H: Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol. 185:302–312. 2010. View Article : Google Scholar : PubMed/NCBI
10	Jiang XX, Zhang Y, Liu B, et al: Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood. 105:4120–4126. 2005. View Article : Google Scholar : PubMed/NCBI
11	Zhu KJ, Shen QY, Cheng H, Mao XH, Lao LM and Hao GL: Triptolide affects the differentiation, maturation and function of human dendritic cells. Int Immunopharmacol. 5:1415–1426. 2005. View Article : Google Scholar : PubMed/NCBI
12	Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P and Gluckman JC: Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol. 27:431–441. 1997. View Article : Google Scholar : PubMed/NCBI
13	Dolganiuc A, Kodys K, Kopasz A, et al: Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol. 170:5615–5624. 2003. View Article : Google Scholar : PubMed/NCBI
14	Wang X, Gao XH, Hong Y, Li X and Chen HD: Local hyperthermia decreases the expression of CCL-20 in condyloma acuminatum. Virol J. 7:3012010. View Article : Google Scholar : PubMed/NCBI
15	Abe M, Akbar SM, Horiike N and Onji M: Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver. J Hepatol. 34:61–67. 2001. View Article : Google Scholar
16	Banchereau J, Briere F, Caux C, et al: Immunobiology of dendritic cells. Annu Rev Immunol. 18:767–811. 2000. View Article : Google Scholar
17	Zhu KJ, Cen JP, Lou JX, et al: Imiquimod inhibits the differentiation but enhances the maturation of human monocyte-derived dendritic cells. Int Immunopharmacol. 9:412–417. 2009. View Article : Google Scholar : PubMed/NCBI
18	Piemonti L, Monti P, Sironi M, et al: Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol. 164:4443–4451. 2000. View Article : Google Scholar : PubMed/NCBI
19	Frison N, Taylor ME, Soilleux E, et al: Oligolysine-based oligosaccharide clusters: selective recognition and endocytosis by the mannose receptor and dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin. J Biol Chem. 278:23922–23929. 2003. View Article : Google Scholar
20	Horváth R, Budinský V, Kayserová J, et al: Kinetics of dendritic cells reconstitution and costimulatory molecules expression after myeloablative allogeneic haematopoetic stem cell transplantation: implications for the development of acute graft-versus host disease. Clin Immunol. 131:60–69. 2009.
21	Ferrer IR, Liu D, Pinelli DF, Koehn BH, Stempora LL and Ford ML: CD40/CD154 blockade inhibits dendritic cell expression of inflammatory cytokines but not costimulatory molecules. J Immunol. 189:4387–4395. 2012. View Article : Google Scholar : PubMed/NCBI
22	Wakim LM and Bevan MJ: Cross-dressed dendritic cells drive memory CD8⁺ T-cell activation after viral infection. Nature. 471:629–632. 2011. View Article : Google Scholar : PubMed/NCBI
23	Cervantes-Barragan L, Lewis KL, Firner S, et al: Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci USA. 109:3012–3017. 2012. View Article : Google Scholar : PubMed/NCBI
24	Schreiber HA, Hulseberg PD, Lee J, et al: Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model. PLoS One. 5:e114532010. View Article : Google Scholar : PubMed/NCBI
25	Dullaers M and Thielemans K: From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy. J Gene Med. 8:3–17. 2006. View Article : Google Scholar : PubMed/NCBI
26	Koski GK, Lyakh LA, Cohen PA and Rice NR: CD14⁺ monocytes as dendritic cell precursors: diverse maturation-inducing pathways lead to common activation of NF-kappab/RelB. Crit Rev Immunol. 21:179–189. 2001.